Davion Healthcare Plc IPO: offering terms from its F-1
Davion Healthcare Plc filed its F-1 on 4 Aug 2025 to list on Nasdaq as DAVI, and has amended it 3 times. It has not set a price range yet.
Headlines
- Net loss, 2024
- 1M EUR
- Price range
- Not set yet
Davion Healthcare Plc IPO terms
From the newest registration statement. Terms left blank there are not set yet.
- Exchange
- Nasdaq Global Market
- Ticker
- DAVI
- Price range
- Not set yet
- Shares offered
- Not set yet
- Expected to raise
- Not set yet
- Registered
- $250M, the amount the filing fee is paid on
- First filed
- 4 Aug 2025
Davion Healthcare Plc revenue and profit
In EUR, the currency the company reports in.
| Period | Revenue | Operating income | Net income |
|---|---|---|---|
| 2024 | - | -1M EUR | -1M EUR |
| First half of 2025 | - | -277,441 EUR | -277,441 EUR |
Davion Healthcare Plc share structure and company facts
- Headquarters
- Cork, Ireland
Davion Healthcare Plc's IPO filings
The registration statement, each amendment and the final prospectus, oldest first.
About the data
- Terms and financials are read from Davion Healthcare Plc's newest prospectus (F-1/A filed 5 Dec 2025) by a Kadoa workflow. Check figures that matter against the filing.
- Registered is the amount the filing fee is paid on, often a placeholder before the price range is set.
- Raised is the IPO price times the shares sold, without the underwriters' option. Trading compares the first and latest close with the IPO price.